Enasidenib (Idhifa,Enasidx)

Enasidenib's innovative therapy offers a new treatment option for AML patients who are unresponsive to or experience relapse with conventional therapies.

50mg*30tablets
100mg*30tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Enasidenib Medication Guide

Enasidenib(Idhifa)

Indications：Enasidenib's innovative therapy offers a new treatment option for AML patients who are unr···

WhatsApp
Official Service

FDA Warns: Symptoms of Serious Blood Cell-Related Disorders Caused by Enasidenib Leukemia Drug Not B

On November 29, 2018, the U.S. Food and Drug Administration (FDA) warned that symptoms of differentiation syndrome, a life-threatening side effect of ···【More】
Update: 09 Mar,2026Source: BigbearViews: 135
Enasidenib (English Instructions for Use)

Enasidenib was developed by Celgene in the United States and approved for marketing by the US FDA on August 1, 2017.Enasidenib (English Indicatio···【More】
Update: 09 Mar,2026Source: BigbearViews: 133
Enasidenib Dosage and Administration: Medication Guidelines, Dosage Adjustments

Enasidenib is indicated for adult patients with relapsed or refractory acute myeloid leukemia (AML) who have been diagnosed with an isocitrate dehydro···【More】
Update: 09 Mar,2026Source: BigbearViews: 137